These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13865906)

  • 1. The cardiovascular pharmacology of t-butylamine.
    BAUM T; HORNBROOK KR; VASQUEZ-LEON H; BENNETT DR
    J Pharmacol Exp Ther; 1962 Sep; 137():275-84. PubMed ID: 13865906
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decrease of blood pressure by penhexamine and penbutamine verified by a bloodless rheoplethysmographic method].
    VANECEK M; TRCKA V
    Cesk Fysiol; 1959 Sep; 8():462-3. PubMed ID: 13841239
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of a series of nuclear substituted phenyltertiary-butylamines with particular reference to anorexigenic and central stimulating properties.
    HOLM T; HUUS I; KOPF R; MOLLER NIELSEN I; PETERSEN PV
    Acta Pharmacol Toxicol (Copenh); 1960; 17():121-36. PubMed ID: 13715432
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of histamine by a substituted butylamine (L 1935): comparison with compound 48/80.
    FELDBERG W; LECOMTE J
    Br J Pharmacol Chemother; 1955 Jun; 10(2):254-9. PubMed ID: 14389669
    [No Abstract]   [Full Text] [Related]  

  • 5. VASCULAR DILATOR ACTION OF T-BUTYLAMINE AND ITS DEPENDENCE ON SYMPATHETIC TONE.
    BAUM T; BENNETT DR
    J Pharmacol Exp Ther; 1963 Oct; 142():83-92. PubMed ID: 14076526
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of pressor amines from the adrenal glands of the cat by two histamine analogues.
    LINDELL SE; WESTLING H; WHITE T
    Arch Int Pharmacodyn Ther; 1960 Sep; 127():410-2. PubMed ID: 13762304
    [No Abstract]   [Full Text] [Related]  

  • 7. [DISTRIBUTION AND EXCRETION OF THE GANGLIOPLEGICS N,N,1,2,2-PENTAMETHYLCYCLOHEXYLAMINE AND N,N,2,2,3-PENTAMETHYL-3-BUTYLAMINE AFTER PERORAL ADMINISTRATION IN RATS].
    PLACKOVA Z; HAIS IM
    Cesk Farm; 1963 Jun; 12():242-6. PubMed ID: 14077276
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE PHARMACOLOGY OF 2-PHENYL-3-METHYL-3-BUTYLAMINE, A SUBSTANCE WITH ANOREXIC ACTION].
    BEHRENDT WA; DEININGER R
    Arzneimittelforschung; 1963 Aug; 13():711-6. PubMed ID: 14090434
    [No Abstract]   [Full Text] [Related]  

  • 9. A differential action of ferrous-iron on vascular responses of sympathomimetic amines.
    RAJAPURKAR MV; SACHDEV KS; PANJWANI MH
    Arch Int Pharmacodyn Ther; 1962 Apr; 136():465-75. PubMed ID: 14489978
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of aliphatic monoamines on motor activity of mice: no direct interaction with dopaminergic D2 receptor.
    Widy-Tyszkiewicz E; Członkowski A
    Pol J Pharmacol Pharm; 1983; 35(6):467-72. PubMed ID: 6234517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on ketene and its derivatives. XL. Reaction of diketene with N-ethylideneisopropylamine, N-methyleneclohexylamine, and N-methylene-tert-butylamine].
    Kato T; Yamamoto Y; Sakamoto T
    Yakugaku Zasshi; 1970 Nov; 90(11):1400-5. PubMed ID: 5530450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antispastic activity of N-phenyl-3-methylamino-2-(3,3-diphenylpropylamino) -n-butylamine phosphate (154 DF)].
    MILANI C; BERTI F; TIRONE P
    Arch Ital Sci Farmacol; 1961 Jul; 11():261-9. PubMed ID: 14473807
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic activity of phentermine (phenylt-butylamine).
    BECKER BA
    Toxicol Appl Pharmacol; 1961 Mar; 3():256-9. PubMed ID: 13688436
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic resolution of (R,S)-sec-butylamine using omega-transaminase from Vibrio fluvialis JS17 under reduced pressure.
    Yun H; Cho BK; Kim BG
    Biotechnol Bioeng; 2004 Sep; 87(6):772-8. PubMed ID: 15329935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of some aliphatic amines on the activity of monoamine oxidase in rats].
    Valiev AG
    Farmakol Toksikol; 1968; 31(2):238-40. PubMed ID: 5674685
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of ceruloplasmin on the cardiovascular response to the cortical and peripheral administration of adrenalin].
    MINZ B; NAKAJIMA H; THUILLIER J
    C R Seances Soc Biol Fil; 1959; 153():905-9. PubMed ID: 14422806
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of the use of phenyl-tertiary-butylamine (Wilpo) to reduce weight.
    WELSH AL; EDE M; RUBENKOENIG HL
    Curr Ther Res Clin Exp; 1961 Jun; 3():281-5. PubMed ID: 13784276
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of imipramine on the blood pressure and EKG effects of adrenalin, noradrenalin, hydroxytryptamine and hypertensin].
    KAUMANN AJ; COUSSIO JD; IZQUIERDO JA
    Med Exp Int J Exp Med; 1962; 6():1-13. PubMed ID: 14454495
    [No Abstract]   [Full Text] [Related]  

  • 19. Bradykinin and cardiovascular system: estimation of half-life.
    SAAMELI K; ESKES TK
    Am J Physiol; 1962 Aug; 203():261-5. PubMed ID: 14495729
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats.
    Chen YP; Qiu CR; Wang H
    Life Sci; 2004 Sep; 75(17):2131-42. PubMed ID: 15312756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.